The perioperative protection in HIV/AIDS patients with fracture in China: a systematic review

doi:10.3969/j.issn.1006-7795.2015.04.028

Abstract

Abstract:

The objective for this review was to elucidate the perioperative protective measure in HIV/AIDS patients with fracture in China. In pre-operative period, high active antiretroviral therapy(HAART) must be initiated as an important measure to reduce the incidence of occupational exposure, and healthcare workers should wear face masks and gloves when performing medical practice. In operative period, based on the characteristics of occupational exposure in operations, we took some measures to reduce the risk of occupational exposure, including bilayer gloves, eye mask, disposable waterproof gown, and slippers with foot-strap, advised to minimize the use of sharp or electrical instruments and argon knifes, and advised contactless operation as far as possible to reduce opportunity of occupational exposure. Once occupational exposure occurred in surgical operation, post exposure prophylaxis must be taken immediately. We established perioperative protective measures with Chinese characteristics based on research on orthopedic surgery process in human immunodeficiency virus/acquired immune deficiency syndrome(HIV/AIDS) patients, which helped reduce the risk of occupational exposure in orthopedic surgery.

Key words: acquired immune deficiency syndrome, fracture, perioperative protection, high active antiretroviral therapy

CLC Number:

R512.91

Cai Juan, Zhang Qiang, Xiao Jiang, Yang Fangyu, Li Chunmei, Zhang Hongyu. The perioperative protection in HIV/AIDS patients with fracture in China: a systematic review[J]. Journal of Capital Medical University, 2015, 36(4): 654-658.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2015.04.028

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2015/V36/I4/654

References

[1] Zhang F J, Pan J, Yu L, et al. Current progress of China's free ART program[J]. Cell Res, 2005,15(11-12):877-882.
[2] Zhang F, Haberer J E, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses[J]. AIDS, 2007,21(Suppl 8):S143-S148.
[3] Brown T T, Qaqish R B. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review[J]. AIDS, 2006,20(17):2165-2174.
[4] Triant V A, Brown T T, Lee H, et al. Fracture prevalence among human immunodeficiency virus(HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system[J]. J Clin Endocrinol Metab, 2008,93(9):3499-3504.
[5] Young B, Dao C N, Buchacz K, et al. Investigators.Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study(HOPS) compared with the US general population, 2000-2006[J]. Clin Infect Dis, 2011,52(8):1061-1068.
[6] Ofotokun I, McIntosh E, Weitzmann M N. HIV: inflammation and bone[J]. Curr HIV/AIDS Rep, 2012,9(1):16-25.
[7] Rojo Conejo P, Ramos Amador J T, García Piar L, et al. Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy[J]. An Pediatr(Barc), 2004,60(3):249-253.
[8] Duvivier C, Kolta S, Assoumou L, et al. ANRS 121 Hippocampe study group.Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients[J]. AIDS, 2009,23(7):817-824.
[9] Yin M T, Kendall M A, Wu X, et al. Fractures after antiretroviral initiation[J]. AIDS, 2012,26(17):2175-2184.
[10] Womack J A, Goulet J L, Gibert C, et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans[J]. PLoS One, 2011,6(2):e17217.
[11] Haskelberg H, Hoy J F, Amin J, et al. Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine[J]. PLoS One, 2012,7(6):e38377.
[12] Shiau S, Broun E C, Arpadi S M, et al. Incident fractures in HIV-infected individuals: a systematic review and meta-analysis[J]. AIDS, 2013,27(12):1949-1957.
[13] Peters B S, Perry M, Wierzbicki A S, et al. A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study[J]. PLoS One, 2013,8(10):e78048.
[14] Yoo J J, Chun S H, Kwon Y S, et al. Operations about hip in human immunodeficiency virus-positive patients[J]. Clin Orthop Surg, 2010,2(1):22-27.
[15] Kaplan J E, Benson C, Holmes K K, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America[J]. MMWR Recomm Rep, 2009,58(RR-4):1-207.
[16] Sarrazin U, Brodt R, Sarrazin C, et al. Post-exposure prevention after occupational exposure to HBV, HCV and HIV[J]. Orthopade, 2004,33(2):231-244.
[17] Kuhar D T, Henderson D K, Struble K A, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis[J]. Infect Control Hosp Epidemiol, 2013,34(9):875-892.